LONZA DESIGN2OPTIMIZE
Live / Allowed — Approved for publication (as of 13 Nov 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 01 May 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79456882
- Mark type
- Word mark
- Kind
- Service mark
- Register
- Principal
- Basis
- Madrid Protocol (§66(a))
- International registration
- 1933698
- Filed
- 01 May 2026
- Examining attorney
- Jay Flowers
- Attorney of record
- Lawrence J. Crain
Goods and services
- Class 040 — Treatment of materials: Custom manufacturing, to order and according to third-party specifications, of active pharmaceutical ingredients intended for the pharmaceutical industry and life sciences; Custom manufacturing, to order and according to third-party specifications, of low-molecular-weight active ingredients intended for the pharmaceutical industry and life sciences.
- Class 042 — Scientific and technological services: Technological services provided to third parties for manufacturing active pharmaceutical ingredients, namely technological services for drug development, development of manufacturing processes and drug manufacturing optimization.
Owner
- Lonza Ltd., CH
Prosecution history
- 13 Nov 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Nov 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Nov 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Nov 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Nov 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 09 Nov 2026 — REFUSAL PROCESSED BY MPU
- 10 Sept 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 09 Sept 2026 — NON-FINAL ACTION WRITTEN
- 04 Sept 2026 — ASSIGNED TO EXAMINER
- 28 Aug 2026 — APPLICATION FILING RECEIPT MAILED
- 28 Aug 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Aug 2026 — SN ASSIGNED FOR SECT 66A APPL FROM IB